Mizuho Initiates Coverage On NeuroPace with Outperform Rating, Announces Price Target of $22
NeuroPace, Inc.
NeuroPace, Inc. NPCE | 0.00 |
Mizuho analyst Anthony Petrone initiates coverage on NeuroPace (NASDAQ:
NPCE) with a Outperform rating and announces Price Target of $22.
